glutathione levels and autism in asd patients Brain-derived neurotrophic factor oxidative stress autism: evidence from children and a mouse model Plasma metabolomic signatures in children – Autism and Low Glutathione Levels

In vitro , myricetin treatment of SH-SY5Y neuroblastoma cells exposed to 1-methyl-4-phenylpyridine (MPP + ) significantly reduces Fe 2+ and ROS levels, activates the NRF2/GPX4 signaling pathway, suppresses neuronal ferroptosis, and mitigates cellular injury ( 2+ , ROS, and tumor necrosis factor alpha (TNF-), thereby suppressing neuronal ferroptosis and neuroinflammation and improving learning and memory performance

17507518, vii

All study staff, participants, and parents/legal guardians were blinded to treatment group assignment

But production declines with age, stress, illness, toxin exposure, and poor nutrition